# Novel Therapy for Poor Responders Management

> **NCT04310293** · NA · UNKNOWN · sponsor: **Al Baraka Fertility Hospital** · enrollment: 100 (estimated)

## Conditions studied

- Poor Ovarian Response

## Interventions

- **OTHER:** Femara,Grotwth hormone,HMG

## Key facts

- **NCT ID:** NCT04310293
- **Lead sponsor:** Al Baraka Fertility Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-03-10
- **Primary completion:** 2020-08-01
- **Final completion:** 2020-08-01
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2020-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04310293

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04310293, "Novel Therapy for Poor Responders Management". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04310293. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*